Tenet Healthcare (NYSE: THC) Soars After Strong Q2 Earnings and Goldman Sachs Price Target Hike

• Analyst Confidence: Goldman Sachs reaffirmed a Buy rating and significantly increased its price target for Tenet Healthcare, signaling strong confidence in the healthcare services provider.
• Robust Financial Performance: Tenet Healthcare reported adjusted earnings per share (EPS) of $6.12, surpassing analyst estimates by 50% and demonstrating substantial year-over-year revenue growth.
• Positive Market Reaction: Following the strong results and analyst upgrade, Tenet Healthcare's shares experienced a significant single-day increase, trading near its 52-week high and boosting its market capitalization.

On July 28, 2026, Goldman Sachs reaffirmed its confidence in Tenet Healthcare (NYSE: THC) by maintaining a Buy rating. The investment bank also increased its price target for the healthcare services company to $305 from $252. Tenet Healthcare operates a diverse network of hospitals and outpatient centers across the United States.

The positive analyst rating follows Tenet Healthcare's strong performance in the second quarter of 2026. The company reported adjusted earnings per share (EPS) of $6.12. This figure surpassed the Zacks Consensus Estimate by a remarkable 50% and represents a 52.2% increase compared to the same period last year.

This performance is driven by a 6.8% year-over-year increase in net operating revenues, which reached $5.63 billion. As highlighted by Business Wire, the company's CEO noted that strong same-store revenue growth and effective expense management were key factors. This growth was also helped by higher patient acuity, meaning the company treated more complex cases.

Following these results, Tenet Healthcare raised its financial outlook for the full year of 2026. The company also demonstrated confidence by repurchasing $1 billion of its own shares during the quarter. Share repurchases reduce the number of shares on the market, which can help increase the value of the remaining shares.

The stock market has responded positively to this news. Shares of Tenet Healthcare saw a significant single-day increase of 7.92%, or $19.27 per share, closing at $262.63. The stock is trading near its 52-week high of $262.68, giving the company a market capitalization of approximately $22.62 billion.